All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - PRO.

3 September 2019 (11:45 - 12:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail

Aspirin is out for primary prevention of cardiovascular disease - PRO.

Professor J. Armitage (Oxford, GB)

Presentation thumbnail

Aspirin is out for primary prevention of cardiovascular disease - CON.

Professor C. Patrono (Rome, IT)

Presentation thumbnail

Aspirin is out for primary prevention of cardiovascular disease - Discussion.

Presentation thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Doctor T. Cuisset (Marseille, FR)

Presentation thumbnail

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - Discussion.

Access the full session

Session thumbnail

Controversies in antithrombotic treatment for primary and secondary prevention

The Event

ESC Congress 2019

3 September 2019 11:45 CET

You may be interested in

Congress Presentation

Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension

Congress Session

Challenges in hypertension management

ESC TV Today

Episode 7: Coronary spasm - Sex differences in heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources